The U.S. Food and Drug Administration (FDA) announced on October 23, 2023, its recommendation to lift the voluntary hold on the gene therapy treatment, Elevidys, developed...
GlaxoSmithKline (GSK) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has extended the review period for its blood cancer therapy, Blenrep. This development...
The World Health Organization (WHO) has officially recommended Gilead Sciences’ newly approved HIV pre-exposure prophylaxis (PrEP) medication, Yeztugo (lenacapavir). This endorsement follows its approval by the...
